Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
200.00    -2.20 (-1.09%)
Bid:
199.70
Ask:
200.00
Spread: 0.30 (0.15%)
Market Cap: £1.72b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
25th Jan 202112:51 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSQ3 Trading Update
11th Jan 202112:24 pmRNSResult of General Meeting
5th Jan 20217:00 amRNSDirectorate Change
4th Jan 202111:47 amRNSTotal Voting Rights
17th Dec 20204:26 pmRNSHolding(s) in Company
17th Dec 20204:20 pmRNSHolding(s) in Company
15th Dec 20201:32 pmRNSDirector/PDMR Shareholding
14th Dec 20207:04 amRNSNotice of GM and Proposed Capital Reduction
1st Dec 202012:00 pmRNSTotal Voting Rights
10th Nov 20207:00 amRNSHalf-year Report
6th Nov 20207:00 amRNSDisposal
4th Nov 20201:49 pmRNSComment on media speculation re: Hovis
2nd Nov 202010:00 amRNSTotal Voting Rights
9th Oct 20203:58 pmRNSHolding(s) in Company
6th Oct 20203:16 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSPartial redemption of Senior Secured Notes
2nd Oct 20203:26 pmRNSHolding(s) in Company
1st Oct 20203:32 pmRNSBlock listing Interim Review
1st Oct 20201:45 pmRNSTotal Voting Rights
25th Sep 202012:38 pmRNSDirector/PDMR Shareholding
1st Sep 202011:30 amRNSTotal Voting Rights
19th Aug 20203:23 pmRNSDirector/PDMR Shareholding
14th Aug 20203:29 pmRNSHolding(s) in Company
14th Aug 20203:27 pmRNSHolding(s) in Company
14th Aug 20203:17 pmRNSHolding(s) in Company
12th Aug 20202:00 pmRNSResult of AGM
3rd Aug 202011:55 amRNSTotal Voting Rights
29th Jul 20207:00 amRNSQ1 Trading Update
22nd Jul 20207:00 amRNSNotification of Trading Update
7th Jul 20202:07 pmRNSNotice of AGM
1st Jul 20203:04 pmRNSTotal Voting Rights
26th Jun 20203:02 pmRNSDirector/PDMR Shareholding
25th Jun 202012:40 pmRNSDirector/PDMR Shareholding
24th Jun 20207:00 amRNSPreliminary Results
16th Jun 20207:00 amRNSNotice of Results
1st Jun 202011:55 amRNSTotal Voting Rights
26th May 20207:00 amRNSPartial redemption of Senior Secured Notes
15th May 20207:00 amRNSNon-Executive Director Appointments
6th May 20207:00 amRNSPreliminary results announcement timing
1st May 202011:58 amRNSTotal Voting Rights
22nd Apr 20204:01 pmRNSHolding(s) in Company
20th Apr 20207:00 amRNSStrategic Review, Pensions & Trading Update
1st Apr 20201:47 pmRNSBlock listing Interim Review
1st Apr 20201:23 pmRNSTotal Voting Rights
25th Mar 202012:08 pmRNSSecond Price Monitoring Extn
25th Mar 202012:03 pmRNSPrice Monitoring Extension
24th Mar 20204:00 pmRNSHolding(s) in Company
24th Mar 20203:00 pmRNSHolding(s) in Company
20th Mar 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.